US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition – thenewsexp
The Federal Trade Commission is challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic
US drug control agency is moving to
New Jersey seeks fourth round of offshore